Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 06/08/2012 17810_de.jpg

    VivaCell Biotechnology GmbH investigates the health-promoting effect of food

    VivaCell Biotechnology GmbH offers in vivo and in vitro demonstration of the efficacy of pharmaceutical and phytopharmaceutical compounds and nutraceuticals. Using its specific in vitro and in vivo models, the company has been able to prove the health-enhancing effect of numerous foods, and is thus an excellent partner in the Bioactive Plant Foods Network.

    https://www.gesundheitsindustrie-bw.de/en/article/news/vivacell-biotechnology-gmbh-investigates-the-health-promoting-effect-of-food
  • Press release - 11/09/2015

    Venneos raises seed round of 1 million euros

    Venneos GmbH is based in Stuttgart and develops a novel imaging system for the analysis of biological cells. A consortium of business angels and family offices, along with the High-Tech Gründerfonds and Max Planck Society invest in the company to develop a market-ready product and prepare the market entry of the first product generation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/venneos-raises-seed-round-of-1-million-euros
  • Article - 14/11/2011 In the laboratory of BioTeSys

    BioTeSys GmbH - The basics of substance testing

    Esslingen-based BioTeSys GmbH is contracted by its clients to determine the bioactive potential of substances and substance mixtures of foods and dietary supplements. Substances are tested whether or not they have a positive effect on human health using a range of chemical analyses, cell-based tests and clinical trials.

    https://www.gesundheitsindustrie-bw.de/en/article/news/biotesys-gmbh-the-basics-of-substance-testing
  • Press release - 05/09/2011 12851_de.png

    Sequenom announces European licensing agreement with GATC daughter LifeCodexx

    Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/sequenom-announces-european-licensing-agreement-with-gatc-daughter-lifecodexx
  • Guest article - 15/04/2013 Excursion with friends

    Varied and multi-facetted – life and research in Nanjing

    Joachim Koepff spent six months in Nanjing from June to November 2012 doing practical training at the College for Biotechnology and Pharmaceutical Engineering. Here he recounts his experiences in China and his thoughts about the Baden-Württemberg Ministry of Science Research and the Arts scholarship that makes such short-term research stays at a Chinese research institution possible.

    https://www.gesundheitsindustrie-bw.de/en/article/news/varied-and-multi-facetted-life-and-research-in-nanjing
  • Press release - 24/05/2017

    High-Tech Gründerfonds (HTGF) invests in Reutlingen-based SIGNATOPE GmbH – Safe medications thanks to new test procedures

    High-Tech Gründerfonds is investing EUR 600,000 in Reutlingen-based SIGNATOPE GmbH. SIGNATOPE will use the funds to advance the development of its unique biomarker assay system, that has been established to support pharmaceutical research. The technology is based on special antibodies and allows the early detection of possible side effects during the drug development process. Thereby, the need for animal testing will be reduced while the drug…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/high-tech-gruenderfonds-htgf-invests-in-reutlingen-based-signatope-gmbh-safe-medications-thanks-to-new-test-procedures
  • Article - 16/12/2013 Piece of gel on a finger.

    Cellendes puts paradigm change in cell research to good use

    Cells grown on the flat furfaces of tissue culture plates do not behave as they would in their natural environment. This is why scientists are now using three-dimensional substrates to replicate the natural environmental of cells in tissue cellular matrix. Dr. Brigitte Angres and Dr. Helmut Wurst founders and managing directors of Cellendes GmbH in Reutlingen have taken advantage of this new knowledge and developed two novel hydrogels for cell…

    https://www.gesundheitsindustrie-bw.de/en/article/news/cellendes-puts-paradigm-change-in-cell-research-to-good-use
  • Press release - 20/04/2011

    Successful pilot study for non-invasive prenatal diagnostic test to determine trisomy 21

    Scientists from the Center for Prenatal Diagnosis and Human Genetics, Kudamm-199, in Berlin have been working with scientists from GATC Biotech AG and LifeCodexx AG to develop a non-invasive diagnostic test based on Next Generation Sequencing which reliably detects a fetal trisomy 21 (Down syndrome).

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/successful-pilot-study-for-non-invasive-prenatal-diagnostic-test-to-determine-trisomy-21
  • Article - 09/12/2013 Schematic representation of a hybridisation experiment: A short labelled single-stranded DNA probe (red) can bind to a complementary sequence in the DNA against which it is to be compared. The two strands anneal, forming hybrid double-stranded DNA. The sequences bind more firmly the more similar they are.

    Stronger base pairing improves DNA analyses

    A team from the Institute of Organic Chemistry at Stuttgart University has found a chemical substitute for one of the four primary DNA building blocks, i.e. thymine. Thymine can cause problems in DNA hybridisation experiments. The thymine substitute called “E”, which stands for ethynylpyridone, binds more strongly and selectively with the adenine base on the complementary DNA strand than thymine. Highly specific DNA tests might benefit from the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/stronger-base-pairing-improves-dna-analyses
  • Article - 03/07/2018 Laboratory technician wearing a white lab coat and data goggles, sitting at a hood, pipetting liquid into a laboratory vessel.

    The digital laboratory is picking up speed

    A new team at the Fraunhofer IPA is developing digital laboratory systems to support industrial partners in planning and managing laboratory processes. This benefits companies in terms of quality assurance, economic efficiency and, notably, ergonomic improvements to the work place.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-digital-laboratory-is-picking-up-speed
  • Dossier - 01/02/2008 The pericellular coat around an adherent cartilage cell (chondrocyte), visualized by an exclusion assay. A halo of several micrometers in thickness around the cell cannot be penetrated by the dense population of surrounding probe objects (red blood cells)

    Glycobiotechnology - sugar research is picking up speed

    Alongside DNA and proteins sugar structures play an important role in cellular transport and communication processes. They are also part of the molecular control and regulation machinery making them of particular interest to biotechnologists. The pharmaceutical industry as well as the food sector and material sciences have realised the potential of sugar structures.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/glycobiotechnology-sugar-research-is-picking-up-speed
  • Article - 18/09/2010 The photo shows biofilm traces in a washing machine.<br />

    Empa Testmaterials: assessing the effectiveness of washing processes

    Empa Testmaterials AG focuses on the research and development of test systems and materials that enable biofilm to be successfully removed from washing machines as well as controlling the level of hygiene of individual wash cycles. As a competence centre in washing and cleaning the company specialises in the assessment of washing and cleaning processes in terms of effectiveness energy efficiency damage and hygiene.

    https://www.gesundheitsindustrie-bw.de/en/article/news/empa-testmaterials-assessing-the-effectiveness-of-washing-processes
  • Press release - 16/07/2021

    Corona test with cotton swab

    To diagnose an infection with the coronavirus, usually a throat swab is taken and genetic viral material detected by using a highly sensitive PCR. To date, more than 65 million of these tests have been performed in Germany alone. Due to the massive increase in testing worldwide and simultaneous loss of production, there was a significant shortage of test materials in the early stage of the pandemic.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/corona-test-cotton-swab
  • Article - 24/09/2015 ESEQuant_LR3.jpg

    New test system for detection of HPV-related oral cavity cancers

    The number of people suffering from oral or oropharyngeal cancer is rising steadily. The major cause of these cancers is human papillomaviruses (HPV) that colonise the oral cavity, where they are difficult to detect. QIAGEN Lake Constance GmbH from Stockach, in cooperation with Abviris Deutschland GmbH, has developed a new test system to improve the detection of oral HPV. This new system enables rapid and reliable quantitative detection of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-test-system-for-detection-of-hpv-related-oral-cavity-cancers
  • Expert interview - 17/10/2018 Porträtfoto von Dr. Ralf Schumacher

    Biologicals are becoming increasingly important to Boehringer Ingelheim

    Biopharmaceuticals are playing an increasingly important role in Boehringer Ingelheim’s development pipeline. Visible evidence of this is the company’s Biologicals Development Centre (BDC) that is currently being constructed in Boehringer Ingelheim’s Biberach plant and will bring the company’s process development under one roof by early 2020. Walter Pytlik from BIOPRO talked with Dr. Ing. Ralf Schumacher about the new centre.

    https://www.gesundheitsindustrie-bw.de/en/article/news/biologicals-are-becoming-increasingly-important-to-boehringer-ingelheim
  • Article - 05/11/2010 12821_de.jpg

    DITABIS: Custom-made analysis systems for research and industry

    Outstanding quality, clever product design, flexibility and rapid implementation make Pforzheim-based DITABIS Digital Biomedical Imaging Systems AG a true racing stable for device developments. The company’s key competences include imaging plate technology and fluorescence scanning, procedures that can be used to record high-resolution digital images in a contrast-rich and highly linear way. The innovative imaging systems are predominantly used…

    https://www.gesundheitsindustrie-bw.de/en/article/news/ditabis-custom-made-analysis-systems-for-research-and-industry
  • Article - 09/08/2010 The photo shows a green building.

    IBAM GbR - Enzymes, neurotransmitters and Greek mountain tea

    The Denzlingen-based company IBAM GbR offers solutions that enable faster and cost-effective drug discovery. IBAM GbR was spun off from the University of Freiburg and supports industrial customers in identifying biochemical targets of potential drugs or the modes of action of enzymes and second messengers in the central nervous system and other tissues. Over the last few years the companys managing director Dr. Rainer Knörle and his partner Dr.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/ibam-gbr-enzymes-neurotransmitters-and-greek-mountain-tea
  • Press release - 20/01/2008 Building of GATC Biotech AG in Konstanz

    LifeCodexx AG - Clarity within the genetic data jungle

    Constance based GATC Biotech founds the subsidiary company LifeCodexx AG. LifeCodexx is the first web-based information service for the storage and utilisation of biological and medical data from the analysis of genetic codes and protein codes in the EU.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/lifecodexx-ag-clarity-within-the-genetic-data-jungle
  • Article - 25/02/2013 19237_de.jpg

    Molecular monitoring of premature infants

    Premature births are not uncommon in Germany where around seven percent of newborns are born before week 37 of pregnancy. The WHO estimates that the numbers of preterm births are growing due to the increasing age of mothers. Doctors caring for the tiny patients are faced with a dilemma because regular blood samples required for the clinical monitoring of important blood parameters cannot be taken due to the infants low body volume.

    https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-monitoring-of-premature-infants
  • Diagnostics - 29/01/2018 The schematic shows a continuum of lipoprotein particles or different size and their division into major classes and subclasses.

    New test for extended blood fat analysis

    Cholesterol is seen as the cause of atherosclerosis, a disease that can lead to heart attacks and strokes. However, it now seems that the way cholesterol is packaged may be even more important than high blood cholesterol levels. Nuclear magnetic resonance (NMR) spectroscopy now allows the high-throughput analysis of such lipid packages.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-test-for-extended-blood-fat-analysis
  • Article - 17/12/2012 18972_de.jpg

    rent-a-lab – the bioassay specialist

    rent-a-lab has been offering services to detect and determine the quantity of biomolecules for around ten years. The company is mainly focused on studies related to the binding of biomolecules to GTP-binding protein-coupled receptors, a field that has attracted a great deal of attention following the award of the Nobel Prize in Chemistry 2012 for the identification of this important class of receptors.

    https://www.gesundheitsindustrie-bw.de/en/article/news/rent-a-lab-the-bioassay-specialist
  • Press release - 29/03/2012 12629_de.jpg

    GATC Biotech’s NightXpress sequencing service goes Europe-wide

    GATC Biotech, Europe’s leading sequencing provider, now offers its overnight sequencing service NightXpress Europe wide. This unique overnight service has been made possible by the recently opened European Custom Sequencing Centre in Cologne. In Constance, the company’s headquarters, GATC Biotech is building up the European Genome and Diagnostics Centre.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-s-nightxpress-sequencing-service-goes-europe-wide
  • Article - 03/07/2010 The photo shows the ingredients of Paramirum, including high-quality oils and plant essences.<br />

    Erbasens: Using the power of nature

    Before setting up her own company biologist Dr. Elke Schulz amassed a wealth of knowledge in the pharmaceutical industry. Now she harnesses the power of plants to develop and sell dietary supplements and natural cosmetics. Her company Erbasens specialises in combining high-quality oils and plant essences to create products such as Paramirum that safeguards the effectiveness of the immune system and promotes the bodys defence systems.

    https://www.gesundheitsindustrie-bw.de/en/article/news/erbasens-using-the-power-of-nature
  • Article - 13/10/2014 The photo shows a microfluidic chip and the sample-processing chambers.

    Personalised cancer therapy based on microRNA analysis

    microRNAs are not just required for the regulation of gene expression, their expression signatures also allow conclusions to be drawn on the type and progression of cancer. Sensovation AG is therefore working with partners from industry and clinical research to develop an automated microRNA analysis platform that can detect and evaluate microRNA signatures faster than has previously been possible. The system is designed to make it easier to…

    https://www.gesundheitsindustrie-bw.de/en/article/news/personalised-cancer-therapy-based-on-microrna-analysis
  • Article - 06/08/2012 17713_de.jpg

    varionostic: specialist in epigenetic analyses

    Ulm-based varionostic helps epigenetics researchers to obtain information on gene activity. The company is specifically focused on the analysis of methyl groups (-CH3) that are attached to DNA and turn genes on and off. Just as the field of epigenetics, previously only known to insiders, has emerged as a biomedical area of research, the University of Ulm spin-off has matured and grown over the past six years since it was set up.

    https://www.gesundheitsindustrie-bw.de/en/article/news/varionostic-specialist-in-epigenetic-analyses

Page 4 / 7

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search